<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl2">
 <label>Table 2</label>
 <caption>
  <p>Effect of ginseng on bacterial infections of the respiratory tract</p>
 </caption>
 <alt-text id="alttext0025">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Extract</th>
    <th>Pathogen</th>
    <th>Dosage</th>
    <th>Animal model</th>
    <th>Anti-microbial effect with suggested mechanism</th>
    <th>Ref</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <italic>P. ginseng</italic>
    </td>
    <td>
     <italic>P. aeruginosa</italic> PAO 579
    </td>
    <td>25 mg/kg of body weight sc/day for 14 days</td>
    <td>Female Lewis rats</td>
    <td>Increased PMN and chemiluminescence, activated endotoxin-primed neutrophils. Faster bacterial clearance induced Th1 response and better phagocytosis.</td>
    <td>[
     <xref rid="bib87" ref-type="bibr">87</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>P. quinquefolius</italic>
    </td>
    <td>Nonmucoid 
     <italic>P. aeruginosa</italic> strain (PAO1)
    </td>
    <td>1.25 g, 2.5 g and 5%</td>
    <td/>
    <td>Inhibited bacterial growth and biofilm complexes and modulated the motility, adherence, and production of virulence factors.</td>
    <td>[
     <xref rid="bib88" ref-type="bibr">88</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>P. ginseng</italic>
    </td>
    <td>
     <italic>P. aeruginosa</italic>, planktonic
    </td>
    <td>1.25, 2.5, and 5%</td>
    <td/>
    <td>Upregulated extracellular protein and alginate production. Suppressed production of LasA and LasB and downregulated synthesis of AHL molecules. Bacterial clearance 
     <italic>in vivo</italic> is linked to negative effects on the QS system
    </td>
    <td>[
     <xref rid="bib89" ref-type="bibr">89</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>P. ginseng</italic>
    </td>
    <td>
     <italic>P. aeruginosa</italic> PAO1 strain
    </td>
    <td>0.25 g and 0.5% oral</td>
    <td>Female Balb/c mice</td>
    <td>Increased bacterial motility and phagocytosis rates, inhibited biofilm formation, induced dispersion and dissolution of mature biofilms, recovered polymeric matrices</td>
    <td>[
     <xref rid="bib90" ref-type="bibr">90</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>P. ginseng</italic>
    </td>
    <td>
     <italic>P. aeruginosa</italic>
    </td>
    <td>250 mg/kg for 7 days SC</td>
    <td>Female CBA/J mice</td>
    <td>Increased IFN-γ and TNF-α, but decreased IL-4. Activated phagocytes and NK cells to clear the bacterial infection and downregulate the antibody response</td>
    <td>[
     <xref rid="bib91" ref-type="bibr">91</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>P. ginseng</italic>
    </td>
    <td>
     <italic>S. pneumoniae</italic>
    </td>
    <td>25, 50, or 100 mg/kg for 15 days</td>
    <td>Male ICR mice</td>
    <td>Serotype-independent attenuation of high morbidity, alleviated bacterial burden in the blood, lungs, and spleen. Increased survival rates and diminished inflammatory cytokine production.</td>
    <td>[
     <xref rid="bib93" ref-type="bibr">93</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>AHL, acylated homoserine lactone; NK, natural killer; PMN, polymorphonuclear neutrophil; QS, quorum sensing; SC, subcutaneous; BAL, bronchoalveolar lavage; Th1, T-helper type 1</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
